Pembrolizumab versus docetaxel for previously treated, PD‐L1‐positive, advanced non‐small‐cell lung cancer (KEYNOTE‐010): a randomised controlled trial
-
- Herbst RSSH
- 作成者
収録刊行物
-
- N Engl J Med
-
N Engl J Med 387 (10027), 1540-, 2016
